Documentatie- en informatiedienst KNMP

Andersson, K. E. (1978) On the Pharmacokinetics of Cephalosporin Antibiotics,Scand. J. Infect. Dis. Suppl. 13, 37–46.Google Scholar

Andersson, K. E., A. M. Geddes, P. W. Muggleton, R. Norrby, I. Philips, J. R. Saunders enJ. D. Williams (1978) Clinical Aspects of the Second Generation Cephalosporins,Scand. J. Infect. Dis. Suppl. 13, 94–97.Google Scholar

Andrioli, V. T. (1978) Pharmacokinetics of Cephalosporins in patients with normal or reduced renal function,J. Infect. Dis. 137, S 88-S 89.CrossRefGoogle Scholar

Appel, G. B., enH. C. Neu (1977) The nephrotoxicity of antimicrobial agents,New Engl. J. Med. 296, 663–670.CrossRefPubMedGoogle Scholar

Appel, G. B., H. C. Neu, M. F. Parry, M. J. Goldberger enG. B. Jacob (1976) Pharmacokinetics of Cefamandole in the presence of renal failure and in patients undergoing hemodialysis,Antimicrob. Agents Chemother. 10, 623–625.CrossRefPubMedPubMedCentralGoogle Scholar

Barza, M., enP. V. W. Miao (1977) Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics part 3: cephalosporins,Am. J. Hosp. Pharm. 34, 621–629.PubMedGoogle Scholar

Brogard, J. M., F. Comte enM. Pinget (1978) Pharmacokinetics of Cephalosporin antibiotics,Antibiotics Chemother. 25, 123–162.Google Scholar

Brogden, R. N., R. C. Heel, T. M. Speight enG. S. Avery (1979a) Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use,Drugs 17, 1–37; (1979b) Cefuroxime, a review of its antibacterial activity, pharmacological properties and therapeutic use,Ibidem 17, 233–266.CrossRefPubMedGoogle Scholar

Brorson, J. E., enR. Norrby (1978) Comparative in vitro Activity of Cefamandole, Cefoxitin, Cefuroxime and Cephalothin,Scand. J. Infect. Dis. Suppl. 13, 88–93.Google Scholar

Drug Therap. Bull. (1979) Cefamandole, Cefuroxime and Cefoxitin,17, 35–36.Google Scholar

Fabius, G. T. J. (1979)Standaardisatie van gevoeligheidsbepalingen voor antibiotica. Proefschrift, Utrecht.Google Scholar

Gillett, A. P., R. Wise enA. M. Geddes (1978) Use of antibiotics. Infection in the compromised host,Brit. Med. J. 2, 335–337.CrossRefPubMedPubMedCentralGoogle Scholar

Henderson, D. K., A. W. Chow enL. B. Guze (1977) Comparative Susceptibility of Anaerobic Bacteria to Ticarcillin, Cefoxitin, Metronidazole and related antimicrobial agents,Antimicrob. Agents Chemother. 11, 679–682.CrossRefPubMedPubMedCentralGoogle Scholar

Humbert, G., enA. Leroy (1977) Les céfalosporines,La Revue du Practicien 27, 2817–2833.Google Scholar

Medical Letter (1979) Cefamandole and Cefoxitin,21, 13–15.Google Scholar

Meyers, B. R. (1977) The Cephalosporins, Therapist's view,N.Y. State J. Med. 77, 1128–1132.PubMedGoogle Scholar

Moellering, R. C., enM. N. Swartz (1976) The newer cephalosporins,New Engl. J. Med. 294, 24–28.CrossRefPubMedGoogle Scholar

Naumann, P., enH. Rosin (1978) Fortschritte in der antibakteriellen Chemotherapie,Internist 19, 664–671.PubMedGoogle Scholar

Neu, H. C., enK. P. Fu (1978) Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity,Antimicrob. Agents Chemother. 13, 657–664.CrossRefPubMedPubMedCentralGoogle Scholar

Nightingale, C. H., D. S. Greene enR. Quintiliani (1975) Pharmacokinetics and clinical use of cephalosporin antibiotics,J. Pharm. Sci. 64, 1899–1923.CrossRefPubMedGoogle Scholar

Norrby, R. (1978) Newer cephalosporins and cephamycins — a review,Scand. J. Infect. Dis. Suppl. 13, 83–87.Google Scholar

Petz, L. D. (1978) Immunologic cross-reactivity between penicillins and cephalosporins: a review,J. Infect. Dis. 137, S 74-S 79.CrossRefGoogle Scholar

Richmond, M. H. (1978a) Beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillinresistant E. coli,Scand. J. Infect. Dis. Suppl. 13, 11–15; (1978b) Factors influencing the antibacterial action of beta-lactam antibiotics,J. Antimicrob. Chemother. 4 Suppl. B, 1–14.Google Scholar

Sack, K., H. Freiesleben, E. Schulz, R. Marre enW. Henkel (1977) Experimental investigations of cefuroxime in renal tolerance and therapeutic efficacy in pyelonephritis,Proc. Roy. Soc. Med. 70 Suppl. 9, 134–139.PubMedPubMedCentralGoogle Scholar

Sykes, R. B., enM. Matthew (1976) The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics,J. Antimicrob. Chemother. 2, 115–157.CrossRefPubMedGoogle Scholar

Verbist, L. (1976) Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative Bacilli,Antimicrob. Agents Chemother. 10, 657–663.CrossRefPubMedPubMedCentralGoogle Scholar

Vollaard, E. J. (1979) Een nieuw in-vitro-model voor de effectiviteitsbepaling van antibiotica (overzichtsreferaat),Pharm. Weekblad 114, 259–260.Google Scholar

Vuye, A., J. Pijck enH. Soep (1977) Cefalosporinen — huidige perspectieven,Pharm. Weekblad 112, 73–85.Google Scholar

Wise, R. (1978) Use of antibiotics. Cephalosporins,Brit. Med. J. 2, 40–42.CrossRefPubMedPubMedCentralGoogle Scholar